Financials
- Market Capitalization 3.15 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-20.4
Fiyat/satışlar oranı
184.61
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1627 | QURE uniQure N.V. - Ordinary Shares | 49.16 USD | -0.81% | +0.27% | +28.79% | +202.71% | 3.41 B USD | ||
| 1668 | IMNM Immunome, Inc. - Common Stock | 28.26 USD | -2.11% | -2.62% | +21.39% | +185.74% | 3.21 B USD | ||
| 1686 | CLDX Celldex Therapeutics, Inc. - Common Stock | 40.30 USD | -0.40% | -1.52% | +13.27% | +47.94% | 3.16 B USD | ||
| 1688 | IRON Disc Medicine, Inc. - Common Stock | 81.56 USD | -1.20% | +3.14% | +9.54% | +36.27% | 3.13 B USD |